Vanderbilt-Ingram Becomes Member of Prestigious Cancer Alliance
Vanderbilt-Ingram Cancer Center has been named a member of the National Comprehensive Cancer Network (NCCN), an alliance of the world’s leading cancer centers, becoming the organization’s 21st member. The NCCN includes centers dedicated to improving the quality, effectiveness and efficiency of oncology practice so patients can live better lives.
Affiliated with Vanderbilt University Medical Center, Vanderbilt-Ingram is committed to alleviating suffering from cancer through pioneering basic, translational and clinical research; compassionate care for patients, families and survivors; and cancer prevention, outreach and education. The center is led by its interim director, Jennifer Pietenpol, Ph.D., and an executive committee representing all areas of research, medical, surgical and radiation oncology; patient and community education and outreach; public affairs and communications; and other disciplines.
Vanderbilt-Ingram cares for nearly 4,000 new cancer patients each year. A National Cancer Institute-designated Comprehensive Cancer Center, Vanderbilt-Ingram is consistently ranked among the best places for cancer care by U.S. News & World Report and is among the top 10 nationally in competitively awarded NCI grant support.
“We welcome Vanderbilt-Ingram Cancer Center to the NCCN. Vanderbilt-Ingram is one of the nation’s leading cancer centers, with more than $150 million in annual research funding,” said William T. McGivney, Ph.D., Chief Executive Officer of NCCN. “Through their interdisciplinary collaborative methods, VICC is highly regarded as a leader in the development and delivery of high-quality cancer care.”
“Vanderbilt-Ingram is very pleased to join the NCCN,” said Jennifer Pietenpol, Ph.D., interim director at Vanderbilt-Ingram. “Promising discoveries in cancer research are being made every day, but our work is not finished until those findings are translated into advances in patient care. We are excited to join this group of cancer centers to help make that happen.”
Harold L. Moses, M.D., Vanderbilt-Ingram’s founding director and director emeritus, noted that joining NCCN had been a longtime goal of the cancer center. “I am very pleased that we have achieved this goal and we look forward to collaborating with our colleagues to improve cancer care for patients across the country.”
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University, Columbus, OH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
